ReviewBiomedicines2026
Intravascular Imaging Versus Physiology Assessment for Intermediate Lesions During PCI.
Review in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Coronary artery disease (CAD) is the leading cause of mortality, with percutaneous coronary intervention (PCI) constituting the gold standard treatment. However, in an important proportion of the cases, lesion severity is debatable since conventional angiography provides only a two-dimensional representation of the vessel lumen and fails to quantify ischemic significance or plaque morphology. In these cases, several adjunctive tools considering physiology and imaging guidance may assist in quantifying the severity of the disease. Imaging modalities such as intravascular ultrasonography (IVUS) and optical coherence tomography (OCT), as well as physiology such as fractional flow reserve (FFR) and instantaneous wave-free (iFR), revolutionized revascularization strategy by linking anatomical stenosis to its functional consequence on myocardial perfusion. The present review summarizes and contrasts the available evidence for physiology and imaging guidance, considering the assessment of intermediate lesions during PCI and providing insights for their use in specific lesion subsets.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.